Prasugrel Sales Force Poised For FDA Decision In June, Lilly Says

No indication that FDA will call an advisory committee review for prasugrel, according to the firm.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet